Flavonoid Derivatives as New Potent Inhibitors of Cysteine Proteases: An Important Step toward the Design of New Compounds for the Treatment of Leishmaniasis

Leishmaniasis is a neglected tropical disease, affecting more than 350 million people globally. However, there is currently no vaccine available against human leishmaniasis, and current treatment is hampered by high cost, side-effects, and painful administration routes. It has become a United Nation...

Descripción completa

Detalles Bibliográficos
Autores principales: Lourenço, Estela Mariana Guimarães, Di Iório, Juliana Fortes, da Silva, Fernanda, Fialho, Felipe Leonardo Bley, Monteiro, Melquisedeque Mateus, Beatriz, Adilson, Perdomo, Renata Trentin, Barbosa, Euzébio Guimarães, Oses, Jean Pierre, de Arruda, Carla Cardozo Pinto, de Souza Júdice, Wagner Alves, Rafique, Jamal, de Lima, Dênis Pires
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866541/
https://www.ncbi.nlm.nih.gov/pubmed/36677517
http://dx.doi.org/10.3390/microorganisms11010225

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866541/
https://www.ncbi.nlm.nih.gov/pubmed/36677517
http://dx.doi.org/10.3390/microorganisms11010225

Ejemplares similares